摘要
目的对急性心肌梗死心律失常的患者选择门冬氨酸钾镁治疗,研究其疗效。方法在我院于2014年7月—2016年7月治疗的急性心肌梗死心律失常的患者中选择54例,将其展开分组,分组原则为随机平均,其中27例患者选择常规治疗则可作为常规组,剩下的27例患者在常规组的治疗上再加以门冬氨酸钾镁治疗则可作为研究组,以两组患者治疗后血清钾、血清镁含量改善情况及总治疗有效状况为观察指标,进行对比分析。结果治疗后,研究组患者的血清钾、血清镁含量改善情况优于常规组;研究组所治疗取得的总有效率(92.6%)优于常规组(74.1%),P<0.05。结论在对急性心肌梗死心律失常的患者采取治疗措施时加以门冬氨酸钾镁可以提高治疗效果。
Objective To study the efficacy of Potassium Aspartate magnesium in the treatment of arrhythmia in patients with acute myocardial infarction. Methods In our hospital, 54 patients with acute myocardial infarction were treated with arrhythmia from July 2014 to July 2016. They were divided into groups, and the grouping principle was random average. 27 patients were treated with conventional therapy as routine group, The remaining 27 patients in the conventional group on the treatment of Potassium Aspartate magnesium treatment can be used as the study group, two groups of patients after treatment of serum potassium, serum magnesium content improvement and the total effective treatment status as the observation index were analyzed. Results After treatment, the improvement of serum potassium and serum magnesium in the study group was better than that in the conventional group; The total effective rate of the study group （92.6%） was better than that of the conventional group （74.1%）, P 〈 0.05. Conclusion In patients with acute myocardial infarction arrhythmia treatment measures to Potassium Aspartate magnesium can improve the therapeutic effect. potassium
作者
胡广林
HU Guanglin(Department of Internal Medicine, Funing Union Hospital, Yancheng Jiangsu 224400, Chin)
出处
《中国卫生标准管理》
2017年第25期75-76,共2页
China Health Standard Management
关键词
门冬氨酸钾镁
急性心肌梗死
心律失常
potassium aspartate and magnesium aspartate
acute myocardial infarction
arrhythmia
